Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Hepatocellular carcinoma: signaling pathways, targeted therapy, and immunotherapy
Xiaoting Luo, Xin He, Xingmei Zhang, et al.
MedComm (2024) Vol. 5, Iss. 2
Open Access | Times Cited: 32

Showing 1-25 of 32 citing articles:

The Malignant Transformation of Viral Hepatitis to Hepatocellular Carcinoma: Mechanisms and Interventions
Huimin Yuan, Ruochen Xu, Senlin Li, et al.
MedComm (2025) Vol. 6, Iss. 3
Open Access | Times Cited: 1
MASLD-Related HCC: A Comprehensive Review of the Trends, Pathophysiology, Tumor Microenvironment, Surveillance, and Treatment Options
Yuming Shi, Erfan Taherifard, A.I. Saeed, et al.
Current Issues in Molecular Biology (2024) Vol. 46, Iss. 6, pp. 5965-5983
Open Access | Times Cited: 6
Pharmacologically inducing anoikis offers novel therapeutic opportunities in hepatocellular carcinoma
Yumin Wang, Joshua S Fleishman, Jinhua Wang, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 176, pp. 116878-116878
Open Access | Times Cited: 5
Discovery of Potent and Selective c-Met Degraders for Hepatocellular Carcinoma Treatment
Wenjian Min, Huanaoyu Yang, Dawei Wang, et al.
Journal of Medicinal Chemistry (2024)
Closed Access | Times Cited: 4
Gut Microbiota, Deranged Immunity, and Hepatocellular Carcinoma
Emidio Scarpellini, Giuseppe Guido Maria Scarlata, Valeria Santori, et al.
Biomedicines (2024) Vol. 12, Iss. 8, pp. 1797-1797
Open Access | Times Cited: 4
Primary hepatic carcinosarcoma: a case report with insights from retrospective analysis of clinical characteristics and prognostic factors
Zonglei Zhao, Tao Wang, Zhexuan Sun, et al.
Frontiers in Medicine (2025) Vol. 11
Open Access
Diagnostic value of a lactylation-related gene signature in hepatocellular carcinoma
Jiajia Zhang, Chunmei Dong, Lili Wu, et al.
Translational Cancer Research (2025) Vol. 14, Iss. 1, pp. 296-312
Open Access
Nanotechnology-driven EGCG: bridging antioxidant and therapeutic roles in metabolic and cancer pathways
Zahra Esmaeili, Parisa Shavali Gilani, Masood Khosravani, et al.
Nanomedicine (2025), pp. 1-16
Closed Access
Role of MLIP in burn-induced sepsis and insights into sepsis-associated cancer progression
Zhiwei Li, Qian Wang, Ying Liu, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Radioresistance in Hepatocellular Carcinoma: Biological Bases and Therapeutic Implications
Jianhui Wu, Xiaofang Zhao, Bowen Ren, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 5, pp. 1839-1839
Open Access
Artemselenoids A−H, eight guaiane-type sesquiterpenoid dimers from Artemisia selengensis and their antihepatoma activities
Rong‐Fu Chen, Tianze Li, Yun‐Bao Ma, et al.
Organic & Biomolecular Chemistry (2025)
Closed Access
Progress in the Application of Novel Nanomaterials in Targeted Therapy for Liver Cancer
Xin Wei, Weihua Cao, Shiyu Wang, et al.
International Journal of Nanomedicine (2025) Vol. Volume 20, pp. 2623-2643
Open Access
Carfilzomib inhibits the progression of hepatocellular cancer by upregulating GADD45α expression
Mingxun Chen, Chen Xu, Yifang Shui, et al.
Oncology Letters (2025) Vol. 29, Iss. 4, pp. 1-14
Open Access
Integrated Analysis of the Anoikis‐Related Signature Identifies Rac Family Small GTPase 3 as a Novel Tumor‐Promoter Gene in Hepatocellular Carcinoma
Wu Dong, Ze‐Kun Liu, Ying Sun, et al.
MedComm (2025) Vol. 6, Iss. 4
Open Access
Decoding Hepatocellular Carcinoma Metastasis: Molecular Mechanisms, Targeted Therapies, and Potential Biomarkers
Ke Wei, Chunxiu Peng, Yang Ou, et al.
Current Issues in Molecular Biology (2025) Vol. 47, Iss. 4, pp. 263-263
Open Access
UBE4B modulates BET inhibitor sensitivity via KLHL22-JAK2-PIM1 axis in hepatocellular carcinoma
Li Wang, Xia‐Juan Huan, Shanshan Song, et al.
Biochemical Pharmacology (2025), pp. 116943-116943
Closed Access
The anti-metastatic effect of elemene in human hepatocellular carcinoma is potentially mediated by inhibiting a novel driver-circBPTF
Mengyu Yang, Xiaoyu Chen, Yongqian Liu, et al.
Phytomedicine (2025), pp. 156808-156808
Closed Access
The Dual Role of LncRNAs in Hepatocellular Carcinoma: Friend and Foe
Farzaneh Abam, ‪Saeid Ghorbian
Gastroenterology & Endoscopy (2024) Vol. 2, Iss. 4, pp. 186-195
Open Access | Times Cited: 3
Mitochondria-Targeted Icaritin Nanoparticles Induce Immunogenic Cell Death in Hepatocellular Carcinoma
Siyu Chen, Yiyang Sun, Yangla Xie, et al.
ACS Applied Materials & Interfaces (2024)
Closed Access | Times Cited: 3
Immune Microenvironment and the Effect of Vascular Endothelial Growth Factor Inhibition in Hepatocellular Carcinoma
Kyoko Oura, Asahiro Morishita, Tomoko Tadokoro, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 24, pp. 13590-13590
Open Access | Times Cited: 3
Strategies to enhance the response of liver cancer to pharmacological treatments
José J.G. Marı́n, Rocı́o I.R. Macı́as, Maitane Asensio, et al.
AJP Cell Physiology (2024) Vol. 327, Iss. 1, pp. C11-C33
Closed Access | Times Cited: 2
Aptamer-functionalized nanomaterials (AFNs) for therapeutic management of hepatocellular carcinoma
Xiujuan Yin, Jing Rong, Min Shao, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 2
Advancements in Immunotherapeutic Treatments for Hepatocellular Carcinoma: Potential of Combination Therapies
Yusra Zarlashat, Hafiz Salman Mushtaq, Linh Pham, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 13, pp. 6830-6830
Open Access | Times Cited: 2
Exploring the Role of GITR/GITRL Signaling: From Liver Disease to Hepatocellular Carcinoma
Stavros P. Papadakos, Elena Chatzikalil, Georgios Vakadaris, et al.
Cancers (2024) Vol. 16, Iss. 14, pp. 2609-2609
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top